{
    "root": "2fc45f8e-1749-21da-e063-6294a90a939d",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Gabapentin",
    "value": "20250307",
    "ingredients": [
        {
            "name": "STARCH, CORN",
            "code": "O8232NY3SJ"
        },
        {
            "name": "ANHYDROUS LACTOSE",
            "code": "3SY5LH9PMK"
        },
        {
            "name": "TALC",
            "code": "7SEV7J4R1U"
        },
        {
            "name": "GELATIN, UNSPECIFIED",
            "code": "2G86QN327L"
        },
        {
            "name": "SODIUM LAURYL SULFATE",
            "code": "368GB5141J"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP"
        },
        {
            "name": "FERRIC OXIDE YELLOW",
            "code": "EX438O2MRT"
        },
        {
            "name": "GABAPENTIN",
            "code": "6CW7F3G59X"
        }
    ],
    "indications": "Gabapentin is indicated for: \n    • Management of postherpetic neuralgia in adults\n \n                  • Adjunctive therapy in the treatment of partial onset seizures, with and without secondary generalization, in adults and pediatric patients 3 years and older with epilepsy",
    "contraindications": "Postherpetic Neuralgia ( 2.1 ) Dose can be titrated up as needed to a dose of 1800 mg/day Day 1: Single 300 mg dose Day 2: 600 mg/day (i.e., 300 mg two times a day) Day 3: 900 mg/day (i.e., 300 mg three times a day) Epilepsy with Partial Onset Seizures ( 2.2 ) Patients 12 years of age and older: starting dose is 300 mg three times daily; may be titrated up to 600 mg three times daily Patients 3 to 11 years of age: starting dose range is 10 to 15 mg/kg/day, given in three divided doses; recommended dose in patients 3 to 4 years of age is 40 mg/kg/day, given in three divided doses; the recommended dose in patients 5 to 11 years of age is 25 to 35 mg/kg/day, given in three divided doses. The recommended dose is reached by upward titration over a period of approximately 3 days Dose should be adjusted in patients with reduced renal function ( 2.3 , 2.4 )",
    "warningsAndPrecautions": "Gabapentin Capsules USP are supplied as follows: \n    300 mg capsules:\n \n                  Yellow hard gelatin capsules imprinted “215” on body with blue ink, available in:\n                  Bottles of 30: NDC 43063-673-30\n                  Bottles of 45: NDC 43063-673-45\n                  Bottles of 60: NDC 43063-673-60\n                  Bottles of 90: NDC 43063-673-90\n                  Storage \n                  Store at 20° to 25°C (68° to 77°F); [see USP Controlled Room Temperature].",
    "adverseReactions": "Gabapentin is contraindicated in patients who have demonstrated hypersensitivity to the drug or its ingredients."
}